Why the study?
Does standard influenza vaccine increase the rate of MS exacerbations or disease progression in patients with relapsing/remitting multiple sclerosis?
Does standard influenza vaccine increase the rate of MS exacerbations or disease progression in patients with relapsing/remitting multiple sclerosis?
Influenza immunization is safe for patients with relapsing/remitting multiple sclerosis and does not precipitate disease exacerbations or progression.
No takes yet. Share an insight, caveat, or question.
Supports influenza vaccination in relapsing-remitting multiple sclerosis; confirms safety in this randomized population.
Miller et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: